Evrosure

Expel Restenosis Rate
Cobalt Chromium Everolimus
Eluting Coronary Stent

The EvroSure contains Everolimus at a dose of 1.1 µg/mm² provides optimum anti-proliferation and endothelial regeneration, which in-turn assist to reduce Restenosiss.

Detail

For Unbeatable deliverbility which achieves:

Finely engineered elements of an expansive Cobalt Chromium L605 platform, enhances stent flexibility.

The blend of biodegradable PLLA and PLGA polymers with an Integrated Everolimus drug which release in approx 4 – weeks !! Ideal frame work for strength and compatibility.

Other products

Scoreflex PTA

Scroll to Top
Open chat
1
Welcome to PT Revass Utama Medika,

Ready to enhance your medical practice with the best devices?

Chat with us today to discover how we can provide the perfect solutions for your needs!